Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 205-216 of 4,306
Behavioral study icon
Enrolling By InvitationNCT07131137

A Remote Life Balance Training Program for People With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Istanbul
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 65 Years
Countries
Türkiye
Sponsor
Bezmialem Vakif University
Condition
Schizophrenia
Other study type icon
Enrolling By InvitationNCT05165316

European Long-acting Antipsychotics in Schizophrenia study-II

This summary needs review. Please check the official study record and contact the research team for details.

In Ramat Gan
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.Over 18 Years
Countries
Israel
Sponsor
Rene Kahn
Condition
Schizophrenia
Drug study icon
RecruitingISRCTN34863912

Using video feedback to strengthen interactions between parents with psychosis and their young children

This study is testing a medication approach for people with Psychosis or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOther
Countries
United Kingdom
Sponsor
Oxford Health NHS Foundation Trust
Condition
Schizophrenia
Drug study icon
RecruitingNCT05511363

KarXT for Schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in France, in the United Kingdom, ...

Multiple locations, including Orange
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 55 Years to 90 Years
Countries
United States, France, United Kingdom, ...
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
Drug study icon
RecruitingNCT06126224

KarXT for Schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in Canada, in the United Kingdom, ...

Multiple locations, including Stuart
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 55 Years to 90 Years
Countries
United States, Canada, United Kingdom, ...
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
Drug study icon
RecruitingNCT06887192

ML-007C-MA for Schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in France, in Canada, ...

Multiple locations, including Phoenix
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 55 Years to 90 Years
Countries
United States, France, Canada, ...
Sponsor
MapLight Therapeutics
Condition
Schizophrenia
Drug study icon
RecruitingNCT05824728

AGB101 for Schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States.

In Baltimore
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 40 Years to 85 Years
Countries
United States
Sponsor
Johns Hopkins University
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.